Clinical Trial

Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging

Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate the impact of U=U messaging and counseling on gaps in the HIV care cascade for men, including testing uptake and ART initiation (Aim 1), achieving viral suppression and retention in care (Aim 2) in two provinces in South Africa. The U=U message communicates the compelling idea that PLHIV who take ART and have an undetectable viral load (\<200 copies/mL) cannot sexually transmit HIV. Additionally, the investigators will conduct a multi-method evaluation to inform future implementation of U=U messaging interventions (Aim 3).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-10-27; most recent amendment 2024-10-30.
Status change: Not Yet Recruiting → Recruiting 2023-08-03
Trial Details
NCT Number NCT05602376
Lead Sponsor Desmond Tutu HIV Foundation
Collaborators: National Institute of Mental Health (NIMH), National Institutes of Health (NIH), University of Pennsylvania
Conditions HIV Infections, Men, Treatment Adherence
Enrollment 3,642 participants
Start Date 2023-03-31
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-01